Home / Business and Economy / Pharma Deal: Telix Buys ITM in $1.65B Acquisition
Pharma Deal: Telix Buys ITM in $1.65B Acquisition
21 Sep
Summary
- Telix Pharmaceuticals agreed to acquire ITM Isotope Technologies Munich SE.
- The acquisition is valued at approximately $1.65 billion.
- ITM shareholders are set to receive around $1.25 billion in Telix shares.
Australia's Telix Pharmaceuticals announced on Monday its agreement to acquire the German company ITM Isotope Technologies Munich SE. The deal is valued at approximately $1.65 billion on a cash- and debt-free basis.
Following adjustments, shareholders of ITM are anticipated to receive around $1.25 billion in Telix shares. The agreed-upon price for these shares is $11.84 per share. This acquisition represents a substantial expansion for Telix Pharmaceuticals.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
